
浏览全部资源
扫码关注微信
武汉市武东医院/武汉市第二精神病医院精神科
纸质出版日期:2020,
扫 描 看 全 文
[1]陈婷婷,丁凡,刘毅,彭茜,张维,王立忠.丙戊酸镁缓释片在双相情感障碍和焦虑障碍共病治疗中的应用[J].中国医院用药评价与分析,2020,20(04):432-434+437.
CHEN Tingting, DING Fan, LIU Yi, et al. Application of Magnesium Valproate Sustained-Release Tablets in the Treatment of Bipolar Disorder and Anxiety Disorder[J]. 2020,20(4):432-434.
[1]陈婷婷,丁凡,刘毅,彭茜,张维,王立忠.丙戊酸镁缓释片在双相情感障碍和焦虑障碍共病治疗中的应用[J].中国医院用药评价与分析,2020,20(04):432-434+437. DOI: 10.14009/j.issn.1672-2124.2020.04.013.
CHEN Tingting, DING Fan, LIU Yi, et al. Application of Magnesium Valproate Sustained-Release Tablets in the Treatment of Bipolar Disorder and Anxiety Disorder[J]. 2020,20(4):432-434. DOI: 10.14009/j.issn.1672-2124.2020.04.013.
目的:探讨丙戊酸镁缓释片在双相情感障碍和焦虑障碍共病治疗中的应用。方法:选取2015年6月至2018年9月于武汉市武东医院接受治疗的128例双向感情障碍和焦虑障碍共病患者作为研究对象
采用随机数字表法分为对照组和观察组
每组64例。对照组患者采用富马酸喹硫平片进行治疗
观察组患者采用丙戊酸镁缓释片联合富马酸喹硫平片进行治疗。比较两组患者的焦虑状况、精神状况、治疗效果及不良反应发生情况的差异。结果:治疗4、8周末
观察组患者的焦虑量表评分明显低于对照组
差异均有统计学意义(P <0. 05)。治疗4、8周末
观察组患者的阳性与阴性症状量表评分明显低于对照组
差异均有统计学意义(P <0. 05)。治疗4、8周末
观察组患者的总有效率分别为85. 94%(55/64)、95. 31%(61/64)
明显高于对照组的73. 44%(47/64)、79. 69%(51/64)
差异均有统计学意义(P <0. 05);且观察组患者治疗8周末的总有效率明显高于本组治疗4周末
差异有统计学意义(P <0. 05)。观察组患者的不良反应发生率为9. 38%(6/64)
明显低于对照组的31. 25%(20/64)
差异有统计学意义(P <0. 05)。结论:丙戊酸镁缓释片能够显著提高双相情感障碍和焦虑障碍共病患者的治疗效果
与富马酸喹硫平片联合使用具有良好的疗效
对于患者的焦虑狂躁症状具有显著改善作用。
OBJECTIVE: To explore the application of Magnesium valproate sustained-release tablets in the treatment of bipolar disorder and anxiety disorder. METHODS: Totally 128 patients with bipolar disorder and anxiety disorder admitted into Wuhan Wudong Hospital from Jun. 2015 to Sept. 2018 were extracted to be divided into the control group and the observation group via the random number table
with 64 cases in each group. The control group was treated with Quetiapine fumarate tablets
while the observation group received Magnesium valproate sustainedrelease tablets combined with Quetiapine fumarate tablets. The anxiety status
mental status
curative effects and incidence of adverse drug reactions of two groups were compared. RESULTS: After treatment of 4
8 weeks
the anxiety scale score of the observation group was significantly lower than that of the control group
and the difference was statistically significant( P < 0. 05). After treatment of 4
8 weeks
the positive and negative symptom scale scores of the observation group were significantly lower than those of the control group
and the difference was statistically significant( P < 0. 05). After treatment of 4
8 weeks
the total effective rates of the observation group were 85. 94%( 55/64) and 95. 31%( 61/64)
significantly higher than 73. 44%( 47/64) and 79. 69%( 51/64) of the control group
with statistically significant differences( P < 0. 05). The total effective rate of the observation group at the end of 8 weeks was significantly higher than that at the end of 4 weeks
and the difference was statistically significant( P <0. 05). The incidence of adverse drug reactions in the observation group was 9. 38%( 6/64)
significantly lower than31. 25%( 20/64) in the control group
with statistically significant differences( P < 0. 05). CONCLUSIONS:Magnesium valproate sustained-release tablets can significantly improve the treatment effects of patients with bipolar disorder and anxiety disorder
and the combination with Quetiapine fumarate tablets has better curative effects
which can significantly improve the symptoms of anxiety mania in patients.
丙戊酸镁缓释片富马酸喹硫平片双相情感障碍焦虑障碍
Magnesium valproate sustained-release tabletsQuetiapine fumarate tabletsBipolar disorderAnxiety disorder
0
浏览量
81
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621